These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
345 related items for PubMed ID: 20546340
1. Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns. Zynger DL, McCallum JC, Luan C, Chou PM, Yang XJ. Histopathology; 2010 May; 56(6):750-7. PubMed ID: 20546340 [Abstract] [Full Text] [Related]
2. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary. Esheba GE, Pate LL, Longacre TA. Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882 [Abstract] [Full Text] [Related]
3. Alpha-fetoprotein in germ cell tumors. An immunohistochemical study. Chaudhary RK, Kher A, Bobhate SK, Grover S. Indian J Pathol Microbiol; 1989 Jul; 32(3):167-73. PubMed ID: 2476392 [Abstract] [Full Text] [Related]
4. Expression of glypican 3 in ovarian and extragonadal germ cell tumors. Zynger DL, Everton MJ, Dimov ND, Chou PM, Yang XJ. Am J Clin Pathol; 2008 Aug; 130(2):224-30. PubMed ID: 18628091 [Abstract] [Full Text] [Related]
5. Oncofetal protein glypican-3 in testicular germ-cell tumor. Ota S, Hishinuma M, Yamauchi N, Goto A, Morikawa T, Fujimura T, Kitamura T, Kodama T, Aburatani H, Fukayama M. Virchows Arch; 2006 Sep; 449(3):308-14. PubMed ID: 16896894 [Abstract] [Full Text] [Related]
6. Glypican 3: a novel marker in testicular germ cell tumors. Zynger DL, Dimov ND, Luan C, Teh BT, Yang XJ. Am J Surg Pathol; 2006 Dec; 30(12):1570-5. PubMed ID: 17122513 [Abstract] [Full Text] [Related]
7. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Ulbright TM. Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467 [Abstract] [Full Text] [Related]
8. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Cao D, Guo S, Allan RW, Molberg KH, Peng Y. Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406 [Abstract] [Full Text] [Related]
9. FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type. Ricci C, Ambrosi F, Franceschini T, Giunchi F, Di Filippo G, Franchini E, Massari F, Mollica V, Tateo V, Bianchi FM, Colecchia M, Acosta AM, Fiorentino M. Histopathology; 2023 Sep; 83(3):465-476. PubMed ID: 37317674 [Abstract] [Full Text] [Related]
10. Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma. Cheng L, Zhang S, Talerman A, Roth LM. Hum Pathol; 2010 May; 41(5):716-23. PubMed ID: 20096442 [Abstract] [Full Text] [Related]
11. Glypican 3 is a sensitive, but not a specific, marker for the diagnosis of yolk sac tumours. Preda O, Nicolae A, Aneiros-Fernández J, Borda A, Nogales FF. Histopathology; 2011 Jan; 58(2):312-4; author reply 314-5. PubMed ID: 21255065 [No Abstract] [Full Text] [Related]
12. Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more. Kandil DH, Cooper K. Adv Anat Pathol; 2009 Mar; 16(2):125-9. PubMed ID: 19550373 [Abstract] [Full Text] [Related]
13. Gonadal endodermal sinus (yolk sac) tumor with pure intestinal differentiation: a new histologic type. Cohen MB, Friend DS, Molnar JJ, Talerman A. Pathol Res Pract; 1987 Oct; 182(5):609-16. PubMed ID: 2446292 [Abstract] [Full Text] [Related]
14. Diffuse embryoma of the testis. An immunohistochemical study of two cases. de Peralta-Venturina MN, Ro JY, Ordónez NG, Ayala AG. Am J Clin Pathol; 1994 Oct; 102(4):402-5. PubMed ID: 7524298 [Abstract] [Full Text] [Related]
15. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3. Wang F, Liu A, Peng Y, Rakheja D, Wei L, Xue D, Allan RW, Molberg KH, Li J, Cao D. Am J Surg Pathol; 2009 Oct; 33(10):1529-39. PubMed ID: 19574883 [Abstract] [Full Text] [Related]
16. "Somatic-type" malignancies arising from testicular germ cell tumors: a clinicopathologic study of 124 cases with emphasis on glandular tumors supporting frequent yolk sac tumor origin. Magers MJ, Kao CS, Cole CD, Rice KR, Foster RS, Einhorn LH, Ulbright TM. Am J Surg Pathol; 2014 Oct; 38(10):1396-409. PubMed ID: 24921638 [Abstract] [Full Text] [Related]
17. SALL4 is a useful marker for pediatric yolk sac tumors. Wu P, Luo R, Sun B, Zhao J, Xu Q, Feng S, Chen X, Wang C. Pediatr Surg Int; 2020 Jun; 36(6):727-734. PubMed ID: 32222813 [Abstract] [Full Text] [Related]
18. Analysis of GATA3 and FOXA2 expression suggests that downregulation of genes involved in the maintenance of a mature yolk sac tumor phenotype may underlie sarcomatoid transformation. Ricci C, Ambrosi F, Grillini A, Massari F, Fiorentino M, Colecchia M, Ulbright TM, Acosta AM. Virchows Arch; 2024 Apr; 484(4):709-713. PubMed ID: 38141134 [Abstract] [Full Text] [Related]
19. HNF1β is a sensitive and specific novel marker for yolk sac tumor: a tissue microarray analysis of 601 testicular germ cell tumors. Gallo A, Fankhauser C, Hermanns T, Beyer J, Christiansen A, Moch H, Bode PK. Mod Pathol; 2020 Nov; 33(11):2354-2360. PubMed ID: 32561848 [Abstract] [Full Text] [Related]
20. Primary germ cell tumors of the mediastinum: III. Yolk sac tumor, embryonal carcinoma, choriocarcinoma, and combined nonteratomatous germ cell tumors of the mediastinum--a clinicopathologic and immunohistochemical study of 64 cases. Moran CA, Suster S, Koss MN. Cancer; 1997 Aug 15; 80(4):699-707. PubMed ID: 9264353 [Abstract] [Full Text] [Related] Page: [Next] [New Search]